ARLINGTON, Va. — The U.S. National Nuclear Security Administration (NNSA) could soon award a new tranche of funding to support U.S. commercial manufacturing of the medical isotope molybdenum-99 (Mo-99), a senior official said this week.
“We’re working…
SUBSCRIBER ACCESS
Thank you for visiting
RadWaste Monitor!
You must be logged in as a subscriber to view this page.





